{"id":49,"date":"2015-08-07T23:25:27","date_gmt":"2015-08-07T23:25:27","guid":{"rendered":"https:\/\/ipaatentiti.com\/blog\/?p=49"},"modified":"2019-08-29T16:38:06","modified_gmt":"2019-08-29T16:38:06","slug":"new-drug-approvals","status":"publish","type":"post","link":"https:\/\/ipaatentiti.com\/blog\/new-drug-approvals\/","title":{"rendered":"New Drug Approvals"},"content":{"rendered":"\n<p><strong>New Molecular Entity and New Therapeutic Biological Product Approvals<br><\/strong><\/p>\n\n\n\n<table class=\"wp-block-table\"><tbody><tr><td><strong>Drug&nbsp;<\/strong><strong>Name<\/strong><\/td><td><strong>Active Ingredient<\/strong><\/td><td><strong>Date<\/strong><\/td><td><strong>FDA-approved use on approval date<\/strong><\/td><\/tr><tr><td><a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=206843&amp;DrugName=DAKLINZA&amp;ActiveIngred=DACLATASVIR&amp;SponsorApplicant=BRISTOL%20MYERS%20SQUIBB&amp;ProductMktStatus=1&amp;goto=Search.DrugDetails\">Daklinza<\/a><\/td><td>daclatasvir<\/td><td>7\/24\/2015<\/td><td>To treat chronic hepatitis C virus (HCV) genotype 3 infections<\/td><\/tr><tr><td><a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=205266&amp;DrugName=ODOMZO&amp;ActiveIngred=SONIDEGIB&amp;SponsorApplicant=NOVARTIS%20PHARMS%20CORP&amp;ProductMktStatus=1&amp;goto=Search.DrugDetails\">Odomzo<\/a><\/td><td>sonidegib<\/td><td>7\/24\/2015<\/td><td>To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation therapy.<\/td><\/tr><tr><td><a href=\"http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.Set_Current_Drug&amp;ApplNo=125559&amp;DrugName=PRALUENT&amp;ActiveIngred=ALIROCUMAB&amp;SponsorApplicant=SANOFI%20AVENTIS&amp;ProductMktStatus=1&amp;goto=Search.DrugDetails\">Praluent<\/a><\/td><td>alirocumab<\/td><td>7\/24\/2015<\/td><td>To treat certain patients with high cholesterol<\/td><\/tr><\/tbody><\/table>\n","protected":false},"excerpt":{"rendered":"<p>New Molecular Entity and New Therapeutic Biological Product Approvals Drug&nbsp;Name Active Ingredient Date FDA-approved use on approval date Daklinza daclatasvir 7\/24\/2015 To treat chronic hepatitis C virus (HCV) genotype 3 infections Odomzo sonidegib 7\/24\/2015 To treat patients with locally advanced basal cell carcinoma that has recurred following surgery or radiation therapy, or who are not candidates for surgery or radiation [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22,1,4,3],"tags":[],"class_list":["post-49","post","type-post","status-publish","format-standard","hentry","category-drug","category-ipaatentiti","category-ipr","category-patent"],"_links":{"self":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts\/49","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/comments?post=49"}],"version-history":[{"count":2,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts\/49\/revisions"}],"predecessor-version":[{"id":188,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/posts\/49\/revisions\/188"}],"wp:attachment":[{"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/media?parent=49"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/categories?post=49"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipaatentiti.com\/blog\/wp-json\/wp\/v2\/tags?post=49"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}